- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier på Avansert prostatakreft
Totalt 56136 resultater
-
Mayo ClinicNational Cancer Institute (NCI)AvsluttetProstata adenokarsinom | Stadium III prostatakreft | Stage IV prostatakreft | Stage IIA prostatakreft | Stadium IIB prostatakreftForente stater
-
Exact ImagingFullførtProstatakreft | Neoplasma i prostata | Kreft i PROSTATAForente stater
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Institutes of Health (NIH)FullførtProstata adenokarsinom | Stadium III prostatakreft | Stage IV prostatakreft | Stadium IIB prostatakreftForente stater
-
National Cancer Institute (NCI)FullførtProstata adenokarsinom | Fase I prostatakreft | Stage IIA prostatakreft | Stadium IIB prostatakreftForente stater
-
University Health Network, TorontoHar ikke rekruttert ennåAvansert prostatakreftCanada
-
M.D. Anderson Cancer CenterHar ikke rekruttert ennåAvansert prostatakreftForente stater
-
Janssen Research & Development, LLCRekrutteringAvansert prostatakreftFrankrike, Forente stater
-
Jiangsu HengRui Medicine Co., Ltd.Har ikke rekruttert ennåAvansert prostatakreft
-
Jiangsu HengRui Medicine Co., Ltd.RekrutteringAvansert prostatakreftKina
-
Eurofarma Laboratorios S.A.Rekruttering
-
Harpoon TherapeuticsAvsluttetAvansert prostatakreftForente stater, Storbritannia
-
AbbottFraktal.com.pl; Med-net.plFullførtNedre urinveissymptomer | Avansert prostatakreftPolen, Ukraina
-
University of WashingtonNational Cancer Institute (NCI)FullførtProstata adenokarsinom | Stadium III prostatakreft | Stage IV prostatakreft | Stage IIA prostatakreft | Stadium IIB prostatakreftForente stater
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)AvsluttetMetastatisk prostatakarsinom | Prostata adenokarsinom | Stage IV prostatakreft | Hormonresistent prostatakreftForente stater
-
Shanghai Pudong HospitalUTC Therapeutics Inc.TilbaketrukketMesothelin-positive Advanced Refractory Solid TumorsKina
-
Novartis PharmaceuticalsFullførtcMET Dysegulation Advanced Solid TumorsØsterrike, Danmark, Sverige, Storbritannia, Spania, Tyskland, Nederland, Forente stater
-
University of UtahNational Cancer Institute (NCI)RekrutteringUtmattelse | Stillesittende livsstil | Metastatisk prostatakarsinom | Stage IV Prostate Cancer AJCC (American Joint Committee on Cancer) v8 | Stage IVA Prostate Cancer AJCC (American Joint Committee on Cancer) v8 | Stage IVB Prostata Cancer AJCC (American Joint Committee on Cancer) v8Forente stater
-
Providence Health & ServicesMedImmune LLCFullførtProstatakreft | Metastatisk prostatakreft | Kreft i prostataForente stater
-
University of California, San FranciscoGodkjent for markedsføringProstatakreft | Prostata adenokarsinom | ProstataForente stater
-
National Cancer Institute (NCI)FullførtFase I prostatakreft | Fase II prostatakreft | Stadium III prostatakreft | Adenokarsinom i prostataForente stater
-
University of WashingtonNational Cancer Institute (NCI)FullførtFase II prostatakreft | Stadium III prostatakreft | Adenokarsinom i prostata | Stage IV prostatakreftForente stater
-
Abramson Cancer Center of the University of PennsylvaniaFullførtProstatakreft | Fase I prostatakreft | Fase II prostatakreft | Stadium III prostatakreft | Adenokarsinom i prostataForente stater
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.Aktiv, ikke rekrutterendeProstatakreft | Metastatisk prostatakreft | Prostata adenokarsinom | Prostatakreft Metastatisk | Prostata neoplasmaForente stater
-
Atish Choudhury, MDBayer; Pfizer; National Comprehensive Cancer Network; Sumitomo Pharma America...Har ikke rekruttert ennåProstatakreft | Avansert prostatakreft | Hormonsensitiv prostatakreftForente stater
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeSuspendertProstatakreft | Prostata neoplasmaStorbritannia
-
Hongqian GuoAstraZeneca; Nanjing Chia-tai Tianqing PharmaceuticalRekrutteringProstatakreft | Metastatisk prostatakreft | Prostata karsinomKina
-
City of Hope Medical CenterNational Cancer Institute (NCI)FullførtStadium III prostatakreft | Adenokarsinom i prostata | Stage IV prostatakreft | Stadium IIB prostatakreftForente stater
-
National Cancer Institute (NCI)FullførtProstata adenokarsinom | Fase I prostatakreft | Stadium III prostatakreft | Stage IIA prostatakreft | Stadium IIB prostatakreftForente stater
-
Aarhus University HospitalKarolinska University Hospital; Karolinska Institutet; University of Aarhus; Central Denmark Region og andre samarbeidspartnereUkjentProstatakreft | Prostata adenokarsinom | Prostata neoplasmaDanmark
-
University of WashingtonNational Cancer Institute (NCI)FullførtFase II prostatakreft | Stadium III prostatakreft | Adenokarsinom i prostataForente stater
-
John P. FruehaufSanofiTilbaketrukketProstatakreft | Fase I prostatakreft | Fase II prostatakreft | Adenokarsinom i prostata
-
Memorial Sloan Kettering Cancer CenterAktiv, ikke rekrutterendeProstatakreft | Kastrasjonsresistent prostatakreft | Prostata adenokarsinom | Prostatakreft Metastatisk | Prostata neoplasmaForente stater
-
Novartis PharmaceuticalsFullførtKastrasjonsresistent prostatakreft, avansert brystkreftJapan
-
Postgraduate Institute of Medical Education and...RekrutteringProstatakreft | Prostata neoplasmaIndia
-
University College, LondonRekrutteringProstatakreft | Prostata neoplasmaStorbritannia
-
Crozer-Keystone Health SystemRekrutteringProstatakreft | Prostata adenokarsinom | Prostata neoplasmaForente stater
-
Fundacao ChampalimaudUkjentMetastatisk prostatakreft | Prostata adenokarsinomPortugal
-
Mayo ClinicFullførtProstatakreft | Hormonresistent prostatakreft | Adenokarsinom i prostata | Stage IV prostatakreftForente stater
-
National Cancer Institute (NCI)FullførtProstatakreft | Fase I prostatakreft | Fase II prostatakreft | Adenokarsinom i prostataForente stater
-
National Cancer Institute (NCI)FullførtFase I prostatakreft | Fase II prostatakreft | Adenokarsinom i prostataForente stater
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Aktiv, ikke rekrutterendeAvansert prostatakreftForente stater
-
National Cancer Institute (NCI)FullførtTilbakevendende prostatakreft | Fase I prostatakreft | Adenokarsinom i prostata | Stage IIA prostatakreft | Stadium IIB prostatakreftForente stater
-
University of Southern CaliforniaNational Cancer Institute (NCI)AvsluttetMetastatisk prostatakarsinom | Prostata adenokarsinom | Hormonresistent prostatakreftForente stater
-
Royal Marsden NHS Foundation TrustHar ikke rekruttert ennåAvansert prostatakarsinomStorbritannia
-
University of WolverhamptonThe Royal Wolverhampton Hospitals NHS TrustRekrutteringAvansert prostatakarsinomStorbritannia
-
University of California, IrvineFullførtTilbakevendende prostatakreft | Fase I prostatakreft | Stadium III prostatakreft | Adenokarsinom i prostata | Stage IIA prostatakreft | Stadium IIB prostatakreftForente stater
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityFullførtTilbakevendende prostatakreft | Hormonresistent prostatakreft | Adenokarsinom i prostata | Stage IV prostatakreftForente stater
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)FullførtTilbakevendende prostatakreft | Hormonresistent prostatakreft | Adenokarsinom i prostata | Stage IV prostatakreftForente stater
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyFullførtTilbakevendende prostatakreft | Hormonresistent prostatakreft | Adenokarsinom i prostata | Stage IV prostatakreftForente stater
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.AvsluttetTilbakevendende prostatakreft | Hormonresistent prostatakreft | Adenokarsinom i prostata | Stage IV prostatakreftForente stater